Are you searching for a way to meet industry peers and collaborate on complex clinical trial topics?
Hoping to exchange ideas with experts on managing trial risks? Working to dig deeper on performance management with your team? This Metrics Champion Consortium summit is made for you.
While the COVID-19 crisis has changed much of the clinical trial world, the need for experts and professionals to come together and discuss how to successfully assess, manage, and monitor study risks and processes remain the same. Through this extensive summit, you and your team will have the opportunity to delve into the ways metrics — and the careful and critical analysis of those metrics — can help you navigate your clinical trials with thoughtful effort and unprecedented success.
To prepare for this engaging summit, you will have the opportunity to view prerecorded video sessions during the 10 days before the three-day live event. The digital nature of the summit won’t hinder MCC’s usual interactive experience. Participants can join virtual community discussions and working groups, along with a virtual team exercise in data analytics.
Industry experts will share how to manage risk in a high-octane environment, assess risk during and after a pandemic, work toward centralized monitoring, decide on a remote or onsite monitoring process, maintain data quality, run risk-based audits, and manage vendors and partnerships.
Don’t miss out on this chance to connect with your peers and engage around topics that will change your clinical trial practice for the better.
Our goal is to deliver a unique, engaging, interactive, multimedia experience.
Leading the drug-development enterprise in the adoption and utilization of standardized metrics and benchmarks to drive performance improvement. Founded in 2006, MCC is the leading industry association dedicated to the development of standardized performance metrics to improve clinical trials. MCC provides the collaborative environment for biopharmaceutical and device sponsors, service providers and sites to improve clinical-trial development through use of MCC standardized performance metrics.